Employee exercise of share options
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces that certain employees of the Company have exercised their options over 160,000 ordinary shares in the Company.
An application has been made to London Stock Exchange plc for these shares to be admitted to trading on AIM and it is expected that this will become effective at 8.00 a.m. on 4 April 2024.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.